ArticleFrontiers in immunology2021

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid.

Si-Hang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.